TAK
equityTakeda Pharmaceutical Co Ltd · TOKYO STOCK EXCHANGE-TOKYO PRO MARKET
Buy it with play money
Fills at the latest stored close and lands in your paper portfolio
Sign in to buy TAK with $10,000 of play money and watch it from here.
Sign in to tradePrice, and when Congress traded it
Hollow marks where they traded, filled where the filing went public
Hover a marker to see who traded and what it was worth.
If you had bought it yourself
Paid at that day's close, held ever since. No member involved.
Working it out…
Short interest
Shares sold short, as brokers report them to FINRA twice a month
| Settlement date | Shares short | Change | Days to cover |
|---|---|---|---|
| Sep 30, 2026 | 2.92M | -30.6% | 1.2 |
| Sep 15, 2026 | 4.2M | +2.8% | 1.9 |
| Aug 31, 2026 | 4.09M | +36.6% | 1.8 |
| Aug 14, 2026 | 2.99M | +4.4% | 0.8 |
| Jul 31, 2026 | 2.87M | -24.9% | 0.6 |
| Jul 15, 2026 | 3.82M | -27.4% | 1.3 |
| Jun 30, 2026 | 5.26M | -2.0% | 1.9 |
| Jun 15, 2026 | 5.37M | +10.0% | 1.6 |
Largest fails to deliver, the last year
78 settlement days with at least $10,000 of shares sold and not delivered
| Settlement date | Shares | Value |
|---|---|---|
| Nov 13, 2025 | 378.81K | $5.3M |
| Feb 20, 2026 | 228.29K | $4.3M |
| Nov 12, 2025 | 296.14K | $4.1M |
| Dec 22, 2025 | 253.69K | $3.8M |
| Jan 21, 2026 | 233.06K | $3.8M |
Short interest is every broker's short position at the settlement date, reported to FINRA and published about a week and a half later; it does not say who is short. Days to cover is the short position over the average day's trading, and the share of the company is against the shares outstanding on its latest filing. A fail to deliver is the balance of shares sold and not delivered by settlement, from the SEC: it can be a short seller who never borrowed the stock, but is as often a late delivery that clears within days.
What they lobby on
Disclosed to the Senate, largest spend first
- TAKEDA PHARMACEUTICALS AMERICA, INC.$1.4M
Budget/Appropriations, Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code, Trade (domestic/foreign), Defense
1st Quarter (Jan 1 - Mar 31) 2026
- TAKEDA PHARMACEUTICALS AMERICA, INC.$610K
Budget/Appropriations, Medicare/Medicaid, Health Issues, Trade (domestic/foreign), Defense
2nd Quarter (Apr 1 - June 30) 2026
- TODD STRATEGY GROUP$50K
Health Issues, Medicare/Medicaid, Trade (domestic/foreign)
2nd Quarter (Apr 1 - June 30) 2026
- TODD STRATEGY GROUP$50K
Health Issues, Medicare/Medicaid
1st Quarter (Jan 1 - Mar 31) 2026
- TIBER CREEK GROUP$50K
Medicare/Medicaid
2nd Quarter (Apr 1 - June 30) 2026
- CROSSROADS STRATEGIES, LLC$50K
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark, Trade (domestic/foreign), Environment/Superfund
2nd Quarter (Apr 1 - June 30) 2026
- HOLLAND & KNIGHT LLP$50K
Taxation/Internal Revenue Code
1st Quarter (Jan 1 - Mar 31) 2026
- TIBER CREEK GROUP$50K
Medicare/Medicaid, Health Issues
1st Quarter (Jan 1 - Mar 31) 2026
More on TAK
Who traded it
Most active first
| Member | Buys | Sells |
|---|---|---|
| Virginia FoxxNC-05 · house | 2 | 1 |
| Greg GianforteMT-00 · house | 1 | 1 |
| Dan GoldmanNY-10 · house | — | 1 |
Every disclosure
6 in total, newest first
| Member | Amount |
|---|---|
| Virginia FoxxNC · housesell | $15K – $50K |
| Dan GoldmanNY · housesell | $15K – $50K |
| Virginia FoxxNC · housebuy | $1K – $15K |
| Virginia FoxxNC · housebuyjoint | $1K – $15K |
| Greg GianforteMT · houseselljoint | $1K – $15K |
| Greg GianforteMT · housebuyjoint | $15K – $50K |
Follow Takeda Pharmaceutical Co Ltd (TAK) by email
New trades in Takeda Pharmaceutical Co Ltd (TAK) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.